Tryon Medical Group — Charlotte, North Carolina

Tryon Medical Group is a clinical research site located in Charlotte, North Carolina, United States 28210.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Tryon Medical Group has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Colitis, Ulcerative, Crohn's Disease, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol.

Sponsors: Janssen Research & Development, LLC, Janssen Vaccines & Prevention B.V., ModernaTX, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charlotte

Browse all research sites in North Carolina · View every site in Charlotte

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tryon Medical Group?

Tryon Medical Group has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tryon Medical Group conducted?

Tryon Medical Group has 4 clinical trials on record, with 2 currently active. Their work covers Colitis, Ulcerative, Crohn's Disease, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol.

Is Tryon Medical Group accredited by Crixeo Clinical Trials?

Tryon Medical Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tryon Medical Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.